Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo

worldpharmanewsSeptember 07, 2018

Tag: Novartis , Sandoz , Aurobindo

PharmaSources Customer Service